Morepen Laboratories Limited has submitted to the Exchange, the financial results for the quarter and nine months ended December 31, 2025.
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Morepen Laboratories has filed its financial results for the third quarter and nine-month period ending December 31, 2025 with the stock exchange. The filing is a routine compliance submission under listing requirements and does not itself contain the detailed numbers. Investors will need to refer to the actual results document for revenue, profit, and margin figures. The company is in the pharmaceuticals sector and this is its mid-year-to-date earnings update.
This is a procedural submission notice rather than the results themselves, so no immediate price action is expected from this filing alone. Shareholders should review the accompanying financial results PDF for the actual performance numbers.